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Background: Light information is the most important cue of circadian rhythm which synchronizes biological
rhythm with external environment. Circadian misalignment of biological rhythm and external environment is
associated with increased risk of depression, insomnia, obesity, diabetes, cardiovascular disease, and cancer.
Increased light transmission by cataract surgery may improve circadian misalignment and related health outcomes.
Although some observational studies have shown improvement of depression and insomnia after cataract surgery,
randomized controlled trials are lacking. We will conduct a parallel-group, assessor-blinded, simple randomized
controlled study comparing a cataract surgery group at three months after surgery with a control group to
determine whether cataract surgery improves depressive symptoms, sleep quality, body mass regulation, and
glucose and lipid metabolism.
Methods/Design: We will recruit patients who are aged 60 years and over, scheduled to receive their first cataract
surgery, and have grade 2 or higher nuclear opacification as defined by the lens opacities classification system III.
Exclusion criteria will be patients with major depression, severe corneal opacity, severe glaucoma, vitreous
haemorrhage, proliferative diabetic retinopathy, macular oedema, age-related macular degeneration, and patients
needing immediate or combined cataract surgery. After baseline participants will be randomized to two groups.
Outcomes will be measured at three months after surgery among the intervention group, and three months
after baseline among the control group. We will assess depressive symptoms as a primary outcome, using the short
version geriatric depression scale (GDS-15). Secondary outcomes will be subjective and actigraph-measured sleep
quality, sleepiness, glycated haemoglobin, fasting plasma glucose and triglyceride, low-density lipoprotein cholesterol,
high-density lipoprotein cholesterol, body mass index, abdominal circumference, circadian rhythms of physical activity
and wrist skin temperature, and urinary melatonin metabolite. Chronotype and visual function will be assessed using
the ‘morningness-eveningness’ questionnaire, the Munich chronotype questionnaire, and the National Eye Institute
Visual Function Questionnaire.
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Discussion: Although there are potential limitations due to the difference in duration from baseline survey to outcome
measurements between two groups, any seasonal effect on the outcome measurement will be balanced as a result of
continuous inclusion of participants through the year, and outcomes will be adjusted for day length at outcome
measurements at analysis.
Trial registration: UMIN000014559, UMIN Clinical Trials Registry, registered on 15 July 2014.
Keywords: Cataract surgery, Circadian rhythm, Depression, Sleep disturbance, Diabetes mellitusBackground
Light information is the dominant stimulus synchronising
the master internal biological clock at the suprachiasmatic
nuclei (SCN) with the external environment. The internal
biological rhythm of humans is close to that of the earth’s
rotation, according to a study of the rhythm of core body
temperature independent of the external environment
[1]. The misalignment of biological rhythm and external
environment is associated with many health problems.
Epidemiological studies among shift workers suggest that
circadian misalignment is significantly associated with
an increased risk of sleep disturbance [2], depression [3],
obesity and metabolic syndrome [4,5], diabetes [6,7], is-
chaemic heart disease [8,9], and stroke [10]. Light infor-
mation modifies the timing of the internal biological
rhythm according to the phase response curve to light
[11]. Light exposure in the early morning (after core body
temperature minimum) is responsible for the subsequent
phase advance in melatonin secretion; in contrast, light in
the evening (before core body temperature minimum) is
responsible for the subsequent phase delay. Simultan-
eously, the amplitude of the internal biological rhythm is
modified by light information [12].
In contrast to visual light information received by rod
and cone cells of the retina and transmitted via the optic
nerve, non-visual light information is mainly perceived
by recently discovered intrinsically photosensitive retinal
ganglion cells (ipRGCs), which contain melanopsin, and
are transmitted to the SCN via the retinohypothalamic tract
(RHT) [13]. The action spectrum for melatonin suppression
among humans show a peak at a shorter wavelength
(464 nm) than that for visual information (approximately
555 nm) [14].
Cataracts are a prevalent cause of visual impairment
and a leading cause of blindness worldwide. The World
Health Organisation reported that 33% of visual impair-
ment (representing 95 million people) and 51% of blind-
ness (representing 19.9 million people) are due to cataracts
[15]. Among age-related cataract patients, the light trans-
mission at the most sensitive spectrum for the photic
entrainment of internal biological rhythms decreases
from 82% at 10 years to 23% at 80 years [16]. Circadian
misalignment because of the decreased input of lightinformation caused by cataracts may explain the higher
prevalence of depression among cataract patients [17],
and the association of decreased light transmission by lens
yellowing with sleep disturbance [18].
The research hypothesis of the present study is that
cataract surgery, which removes the clouded lens and
implants an artificial intraocular lens (IOL), will increase
the input of non-visual light information and improve
circadian alignment and its related health outcomes,
such as depression, sleep disturbances, body mass regu-
lation, and glucose and lipid metabolism [19].
The hypothesis is supported by studies of bright light
intervention and light exposure in real-life situations.
A Cochrane systematic review showed a significant
reduction of depressive symptoms (standardised mean
difference −0.20, 95% CI −0.38 to −0.01) from a meta-
analysis of 18 randomized controlled trials (RCTs) among
505 patients with non-seasonal depression [20], and an-
other systematic review also revealed the significant effect-
iveness of bright light intervention and light exposure
among seasonal affective disorders (eight RCTs totalling
132 patients) [21]. In addition, recent RCTs have revealed
the effectiveness of bright light therapy on depression,
accompanied by improved sleep quality and internal bio-
logical rhythm. Bright light therapy (pale blue light at
7,500 lux for one hour) significantly decreased depressive
symptoms compared with the placebo control group (red
dim light at 50 lux) among 89 patients with non-seasonal
depression, and was accompanied by an increase in
salivary melatonin in the evening and better actigraph-
measured sleep parameters [22,23]. An intervention to in-
crease light exposure by installing a ceiling light in the
shared living room in group care facilities significantly
decreased depressive symptoms, and increased total sleep
time, as assessed by an actigraph, among elderly partici-
pants. In addition, a significant interaction of light inter-
vention and melatonin administration on sleep efficiency
was observed [24]. Higher daylight exposure increases
melatonin secretion at night, according to an interven-
tional study [25] and our population-based observational
study [26].
Short-term and long-term influence of cataract surgery
on depression and subjective sleep quality have been
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depressive symptoms assessed before cataract surgery,
significant decreases in depressive symptoms have re-
ported at two months [27,28], three months [29], and
one year [30] after surgery. In addition, improved sub-
jective sleep quality was reported at one month [31], two
months [32,33], and nine months [34] after surgery.
However, evidence from RCTs on the effect of cataract
surgery on depressive symptoms, sleep disturbance, and
internal biological rhythms is lacking.
In contrast to bright light therapy conducted during
the daytime, cataract surgery may increase the input of
light information, not only in the daytime, but also dur-
ing the night-time. Increased input of light information
during the night-time may be deleterious to health out-
comes. Indeed, we found significant cross-sectional associ-
ation of increased light at night with increased prevalence
of obesity, dyslipidaemia [35], sleep disturbance [36], and
depression [37] in real-life situations among elderly indi-
viduals. These associations are supported by previous
experimental evidence [38-40].
Here, we will conduct a parallel-group, assessor-
blinded, simple RCT comparing the intervention group
at three months after surgery with the control group at
three months after baseline, to determine whether cataract
surgery modifies the internal biological rhythm and im-
proves its related health outcomes such as depression,
sleep quality, body mass regulation, and glucose and lipid
metabolism.
Methods/Design
All intervention processes associated with the present
study are conducted at Nara Medical University hospital.
The protocol of this study has been registered at the
University Hospital Medical Information Network Clinical
Trials Registry (UMIN-CTR, identifier: UMIN000014559).
The CLOCK-IOL (Cataract Surgery and Circadian
Biological Rhythm among Japanese Older People with
Cataract in Nara, Kansai Region: Influence of Intra Ocular
Lens Implantation) study was approved by the institu-
tional review board of Nara Medical University (ap-
proval number: 13-032). This research complies with the
Declaration of Helsinki. Before enrolment to this study, we
will obtain written informed consent from all participants.
We will include participants continuously through the
year with similar speed, and inclusion of the present
study will finish at the same date as the started year.
After baseline measurements, all participants will be
randomly allocated to either the intervention group or
the control group in a 1:1 ratio without restrictions such
as blocking and stratification. The outcomes among the
intervention group will be measured at three months
after surgery. Among the control group, the outcomes
will be measured at three months after baseline. Thecontrol group will receive delayed cataract surgery shortly
after the outcome measurement (Figure 1).
Participants
We will assess the eligibility of patients in Nara Medical
University Hospital who have been diagnosed as having
cataracts according to the following inclusion and exclu-
sion criteria.
Inclusion criteria
The inclusion criteria for this study are as follows:
1. Patients scheduled for their first cataract surgery,
2. Aged 60 years or over, and
3. Diagnosed with cataracts of grade 2 nuclear
opacification as defined by the lens opacities
classification system III [41].
Exclusion criteria
The exclusion criteria for this study are as follows:
1. Major depression with current therapy,
2. Severe mental illness or dementia,
3. Severe corneal opacities with difficulty in
assessment of lens opacity or fundal examination,
4. Glaucoma with a visual field deficit of at least mean
deviation >14 dB (Humphrey perimeter),
5. Vitreous haemorrhage,
6. Proliferative diabetic retinopathy,
7. Macular edema,
8. Age-related macular degeneration,
9. Patients needing immediate cataract surgery, or
10. Patients needing combined cataract and glaucoma
surgery or combined cataract surgery and vitrectomy.
Intervention
Before the cataract surgery, the axial length of the eye
will be measured with an A-scan UD-6000 (Tomey,
Nagoya, Japan). Yellow aspherical IOL (SN60WF, Alcon,
Fort Worth, Texas, United States), yellow spherical IOL
(SN60AT, Alcon, Fort Worth, Texas, United States), or
clear spherical IOL (SA60AT, Alcon, Fort Worth, Texas,
United States) will be used for the cataract surgery. The
appropriate power of the IOL will be estimated using the
SRK/T formula for each IOL [42]. The kind of IOL used
for the cataract surgery was randomly allocated to yellow
spherical IOL, yellow aspherical IOL, or clear spherical
IOL in a 1:1:2 ratio. After phacoemulsification with a
small incision, IOL will be implanted.
Patients of cataract surgery for both eyes
We include participants undergoing cataract surgery for
single and both eyes. The surgery for both eyes among the
intervention group will be completed within the same
Figure 1 Flow chart of participants.
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will be used for both eyes. Outcomes will be measured at
three months after the latest surgery.
Primary outcome
We will assess depressive symptoms as a primary out-
come of the present study using the short version geriat-
ric depression scale GDS-15. Prevalence of depression,
median of GDS-15, and the mean value of difference be-
tween baseline and three months later will be compared
between the intervention group and the control group.
Secondary outcomes
As secondary outcomes, we will measure subjective and
actigraph-measured sleep quality, sleepiness, glycated
haemoglobin (HbA1c), fasting plasma glucose (FPG), trigly-
ceride (TG), low-density lipoprotein cholesterol (LDL-C),
high-density lipoprotein cholesterol (HDL-C), body mass
index (BMI), abdominal circumference, circadian rhythm of
physical activity and wrist skin temperature, urinary mela-
tonin metabolite, chronotype, post-illumination pupil re-
sponse (PIPR), visual acuity, and subjective visual function.
Self-reported questionnaires
Depressive symptoms are measured using GDS-15; a
self-administered questionnaire consisting of 15 items
[43]. The sensitivity and specificity of GDS-15 compared
with diagnosis according to the Diagnostic and Statistical
Manual of Mental Disorders (fourth edition) was 92.7%
and 54.8% with a cut-off point of four out of five, and
84.8% and 67.7% with a cut-off point of six out of seven,
respectively [44]. According to a meta-analysis about thevalidity of GDS-15, the mean sensitivity was 0.805 and
the mean specificity was 0.750, respectively [45]. A
higher score on the GDS-15 was significantly associated
with self-report and clinician-administered measures
of suicidal ideation [46] and higher rates of suicide
[47]. Subjective sleep quality and daytime sleepiness are
assessed using the Pittsburgh Sleep Quality Index (PSQI)
[48] and the Epworth Sleepiness Scale (ESS) [49,50], re-
spectively. Chronotype and subjective visual function are
determined by the ‘morningness-eveningness’ question-
naire (MEQ) [51], the Munich Chronotype Questionnaire
(MCTQ) [52], and the National Eye Institute Visual
Function Questionnaire (NEI VFQ25) [53,54].
Analysis of venous blood sample
Overnight fasting venous blood samples will be analysed
at a commercial laboratory (SRL Co. Inc., Tokyo, Japan)
using standard clinical chemistry analysis to determine the
concentrations of HbA1c, FPG, TG, LDL-C, and HDL-C.
Morning spot urine
We will measure 6-sulfatoxymelatonin (aMT6-s) in a
morning spot urine sample. Peak nocturnal plasma mela-
tonin is significantly associated with aMT6-s in subsequent
morning spot urine (r = 0.69) [55,56]. Urinary aMT6-s con-
centration will be measured at a commercial laboratory
(SRL Co. Inc. Tokyo, Japan) using an ELISA kit (RE54031;
IBL International, Hamburg, Germany).
Actigraph
Objective sleep will be measured by an actigraph (ActiSleep-
BT Monitor; ActiGraph Inc., Florida, United States), worn
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and a weekend. Participants will be instructed to keep a stan-
dardised sleep diary logging bed time and rising time. Sleep
parameters such as total sleep time, sleep efficiency, sleep
onset latency, and wake after sleep onset will be calculated
with ActiLife 6 (ActiGraph Inc. Florida, USA). A validation
study of this device showed moderate to high agreement with
sleep parameters as measured by polysomnography [57].
Circadian rhythm of physical activity and wrist skin
temperature
Invasively measured biomarkers usually used in laboratory
settings, such as fluctuation of plasma cortisol, melatonin,
and rectal temperature, are difficult to conduct because
they disturb the normal life of participants. To assess the
influence of cataract surgery on internal biological rhythms
using non-invasive methods, we will measure the phase
and amplitude of circadian activity rhythm and the wrist
skin temperature.
According to large-scale prospective cohort studies,
decreased amplitude, later phase, and decreased robust-
ness of circadian activity rhythm showed a significantly
higher hazard ratio for incidents of cognitive disorders,
cancer mortality, and all-cause mortality [58-60]. Wrist
temperature reveals heat loss from arteriovenous anasto-
moses at the skin [61], and shows a mirror image of core
body temperature [62] and blood pressure [63,64]. The
validity of using wrist skin temperature as an acceptable
measure to assess circadian phase is indicated by the sig-
nificant correlation of dim light melatonin onset and the
increase of wrist skin temperature in the evening in real-
life situations (r = 0.76) [65]. The wrist skin temperature
at inside of the wrist, near the radial artery of the dom-
inant arm, will be measured using a temperature data
logger (Thermochron iButton; Maxim/Dallas, Dallas,
Texas, United States) at three-minute intervals [62].
Post-illumination pupil response
By pharmacological blockage of the rod and cone cells,
the melanopsin-associated ganglion cell response is iso-
lated as a slow, maintained depolarisation to light stimu-
lation, which repolarises slowly after light-offset in vitro
[66]. This PIPR is indicated as an index of the sensitivity
of the melanopsin-containing ipRGC pathway [67]. In
the present study, baseline and sustained pupil diameter
after blue and red light stimulation will be measured.
Baseline pupil diameter is the average pupil diameter in
a seven-second period before light onset. Sustained pupil
diameter is the average from 10 to 40 seconds after light
offset. PIPR (mm), PIPR change (%), net PIPR (mm), and
net PIPR change (%) will be calculated as follows [68]:
PIPR mmð Þ ¼ Baseline pupil diameter mmð Þ
−Sustained pupil diameter mmð ÞPIPR change %ð Þ ¼ PIPR=Baseline pupil diameterð Þ
 100
Net PIPR mmð Þ ¼ Blue PIPR−Red PIPR
Net PIPR change %ð Þ ¼ Blue PIPR change %ð Þ
−Red PIPR change %ð Þ
Other variables
Using a standardised questionnaire, trained researchers
will interview participants about basic characteristics, such
as age, gender, smoking and drinking habits, past history of
cardiovascular events, stroke, cancer, medication, house-
hold income, years of education, and history of shift work.
BMI will be calculated as weight per height (kg/m2). Waist
circumference will be measured at the level of the umbil-
icus, in the standing position.
Sample size
According to the HEIJO-KYO study [26], a community-
based cohort study among the elderly (mean age ± stand-
ard deviation: 72 ± 7.1) in the same district as the present
study, the prevalence of depression was 20.0% (101 out of
506) [37]. To detect its 7% difference as significant at a
two-sided α level of 5% with a power of 80%, it was calcu-
lated that 475 participants in each group would be re-
quired. Assuming a dropout of 5%, we estimated that a
total of 1,000 participants would be needed.
Randomization and masking
Allocation concealment will be maintained by central
randomization using computer-generated random se-
quences, independent of care-providers. The results of
the allocation will be masked from the assessors of the
outcomes, but will be available to both the care pro-
viders and the participants.
Statistical analysis
We will compare the outcomes between the control group
and the intervention group based on the intention-to-treat
principle. For missing values due to loss to follow-up after
baseline measurement, we will impute baseline data using
the last observation carried forward (LOCF) method. For
continuous variables with normal distributions, the mean
and standard deviation will be reported. For variables not
distributed normally, the median and interquartile range
will be reported. Means, medians, and proportions will be
compared using the t test, the Mann-Whitney U test, and
the χ2 test, respectively. We will use analysis of covariance
to estimate adjusted mean values and 95% CIs. The preva-
lence of the two groups will be tested using multivariate lo-
gistic regression analysis. To assess the phase, amplitude,
and robustness of the circadian rhythm, we will use the
cosinor model [69], the sigmoidally transformed cosine
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will conduct a subgroup analysis at baseline according to
the severity of cataract and chronotype.
Discussion
To conduct an RCT assessing the long-term effect of cata-
ract surgery is ethically difficult, because the effectiveness
of cataract surgery for visual acuity is established. To assess
the effect of cataract surgery after three months with mini-
mum disadvantage to the control group due to delayed
surgery, we have potential limitations due to the difference
of duration from baseline survey to outcome measure-
ments between the two groups. Compared with the control
group, the intervention group will spend a longer time
from baseline measurement to outcome measurement due
to the duration between baseline and surgery, and it may
distort the results because of a seasonal effect on out-
comes. However, we will continuously include participants
with a similar speed though the year, and will finish this
study at the same date as started in the previous year. As a
result, the number of overestimated outcomes and under-
estimated outcomes due to the seasonal influence will be
balanced between the two groups. In the statistical analysis,
we will compare the outcomes adjusted for seasonal vari-
ables, such as day length at outcome measurement, using
ANOVA for continuous variables and multivariate logistic
regression analysis for categorical outcomes.
Trial status
At the time of submission, the study protocol has been
fixed and registered for clinical trial registration, but the
recruitment of participants has not started. Recruitment
of participants is expected to begin August 2014.
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